Relmada Therapeutics
RLMD
#8408
Rank
NZ$0.51 B
Marketcap
NZ$4.79
Share price
-15.76%
Change (1 day)
-37.02%
Change (1 year)

Relmada Therapeutics (RLMD) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$22.85 Million

According to Relmada Therapeutics's latest financial reports the company's total liabilities are NZ$22.85 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Relmada Therapeutics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$12.93 M-29.15%
2024-12-31NZ$18.25 M-5.33%
2023-12-31NZ$19.28 M-1.81%
2022-12-31NZ$19.63 M-10.93%
2021-12-31NZ$22.04 M26.23%
2020-12-31NZ$17.46 M
2019-06-30NZ$3.87 M-69.33%
2018-06-30NZ$12.64 M572.3%
2017-06-30NZ$1.88 M-58.09%
2016-06-30NZ$4.48 M-80.46%
2015-06-30NZ$22.95 M-25.14%
2014-06-30NZ$30.66 M
2013-08-31NZ$0.04 M396.47%
2012-08-31NZ$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
NZ$3.83 B 16,683.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$0.70 B 2,972.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel